Veon (VEON) Asset Writedowns and Impairment (2009 - 2026)

Veon has reported Asset Writedowns and Impairment for 17 years, with the latest figure at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Asset Writedowns and Impairment changed 0.0% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2026 stood at -$6.0 million (down 300.0% YoY), and the FY2025 full-year result was $9.0 million, up 200.0% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at -$2.0 million, down from -$1.0 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $7.0 million in Q2 2023, with the low at -$34.0 million in Q4 2022.
• Historically, Asset Writedowns and Impairment has averaged -$5.9 million across 5 years, with a median of -$1.5 million in 2024.
• Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment sank 333.33% — and 2023, when it surged 153.85%.
• Veon's Asset Writedowns and Impairment stood at -$34.0 million in 2022, then surged by 120.59% to $7.0 million in 2023, then slumped by 114.29% to -$1.0 million in 2024, then changed by 0.0% to -$1.0 million in 2025, then sank by 100.0% to -$2.0 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at -$2.0 million (Q1 2026), -$1.0 million (Q2 2025), and -$2.0 million (Q1 2025), per Business Quant data.